Depression and perimenopause are genuinely linked: the odds of a major depressive episode roughly double during the transition and stay raised just after it. What published guidance cannot agree on is whether this depression looks different from depression at any other age, and what a clinician should reach for first.
Low mood in your forties gets explained away twice. Once by the world, which files it under stress and a demanding job, and once by you, because those explanations are true and you have no way of knowing what is left over. The research has been unusually clear on one point for a decade, and unusually noisy on everything else.
Why does the risk rise during perimenopause?
Because it does, and it has been measured. Bromberger and colleagues followed 221 women who were premenopausal when they joined the Study of Women’s Health Across the Nation, through 1,698 person years of observation over ten years. Compared with their own premenopausal years, the odds of a major depressive episode were higher when the same women were perimenopausal (odds ratio 1.98) and higher again in early postmenopause (odds ratio 3.86). That held after adjusting for a baseline history of depression, psychotropic medication, very upsetting life events, body mass index and frequent hot flashes. Their conclusion, in their own words: “The risk of major depression is greater for women during and immediately after the menopausal transition than when they are premenopausal.”
Two caveats belong next to those numbers rather than three paragraphs below them. The sample was 221 women, and the perimenopause confidence interval runs from 1.00 to 3.92, so it only just clears no effect at all. And notice what the postmenopause figure does to the tidy story that risk rises during the transition and lifts once it is over. In this model it did not lift. It went up, on an interval so wide, 1.36 to 10.92, that the honest reading is raised, size unclear.
| What was measured | Figure (95% confidence interval) | Source |
|---|---|---|
| Major depressive episode, perimenopause vs premenopause | OR 1.98 (1.00 to 3.92) | Bromberger 2011, SWAN, 221 women, 10 years |
| Major depressive episode, early postmenopause vs premenopause | OR 3.86 (1.36 to 10.92) | Bromberger 2011 |
| History of major depression at baseline, as a predictor throughout | OR 2.98 (1.55 to 5.72) | Bromberger 2011 |
| Family history of depression, independent of menopausal stage | OR 2.24 (1.17 to 4.29) | Colvin 2017, SWAN Mental Health Study, 303 women |
| Late perimenopause or postmenopause, women with no family history | OR 3.36 (1.79 to 6.32) | Colvin 2017 |
| Late perimenopause or postmenopause, women with a family history | OR 1.36 (0.84 to 2.20), not significant | Colvin 2017 |
| Peri or postmenopausal status as a risk for a recurrent episode | Hazard ratio 2.67 to 4.03 | Bromberger 2015, 425 women |
That last pair of rows is the most interesting thing in the table and almost nobody quotes it. Among women with no family history of depression, reaching late perimenopause tripled the odds. Among women who had a family history, menopausal stage made no significant difference, because something else had already raised their risk.
Does depression in perimenopause actually look different?
Here the sources fall out with each other, and the disagreement is worth more to you than either answer on its own.
The 2018 Guidelines for the Evaluation and Treatment of Perimenopausal Depression, written by Maki, Kornstein and colleagues for the North American Menopause Society and the Women and Mood Disorders Task Force of the National Network of Depression Centers, call perimenopause “a window of vulnerability for the development of both depressive symptoms and major depressive episodes”. On presentation, though, they are deflating: “Midlife depression presents with classic depressive symptoms commonly in combination with menopause symptoms (ie, vasomotor symptoms, sleep disturbance), and psychosocial challenges.” Classic. Not exotic. They add that “menopause symptoms complicate, co-occur, and overlap with the presentation of depression”, which is a different claim: the picture is muddled, not new.
An April 2026 review in the Australian Journal of General Practice, by Kulkarni and colleagues, says close to the opposite. It describes early symptoms as “fluctuating anxiety and agitation, followed by intermittent anhedonia, low libido, social withdrawal, cognitive issues (‘brain fog’) and episodic rage”, and states that “perimenopausal depression is unlike MDD, which is characterised by persistent low mood”, with symptoms that “can vary dramatically from week to week”. If you have spent two years fine one week and furious the next, that will land. It is also why rage that arrives out of all proportion to its trigger and waking at 3am with your heart going keep turning up in the same conversation as low mood.
| Document | On what it looks like | On what comes first |
|---|---|---|
| NAMS and NNDC guideline, 2018 (Maki et al.) | “Classic depressive symptoms commonly in combination with menopause symptoms” | “Proven therapeutic options for depression (ie, antidepressants, psychotherapy) are the front-line treatments for perimenopausal depression” |
| Australian Journal of General Practice, April 2026 (Kulkarni et al.) | “Unlike MDD, which is characterised by persistent low mood”; symptoms “can vary dramatically from week to week” | “Hormone therapy should be the first-line treatment for new-onset perimenopausal depression” |
| NICE guideline NG23 | Describes low mood and depressive symptoms arising as a result of the menopause, not a separate illness | Consider hormone replacement therapy for low mood arising as a result of the menopause; consider cognitive behavioural therapy for depressive symptoms alongside hot flashes |
None of that is a recommendation for you, and this article is not going to make one. It is a map of a live disagreement between serious sources about a decision made in a ten minute appointment. Knowing it exists is the difference between thinking your doctor is wrong and knowing which question to ask.
Who is most likely to be affected?
The most repeated finding, and the one that cuts against the popular framing, is prior history. The 2018 guideline states that “most midlife women who experience a major depressive episode during the perimenopause have experienced a prior episode of depression”. This is usually not a bolt from a clear sky. It is more often an old vulnerability meeting a new hormonal environment.
A separate SWAN analysis of 425 women split the question in two and found that the risk factors were not the same for both groups. For women with no lifetime history of major depression, a first episode in midlife tracked with prior medical conditions, physical health limiting daily roles, and trait anxiety. For women with a prior history, recurrence tracked with a history of anxiety disorder and with peri or postmenopausal status itself. Having six or more close friends roughly halved the risk in both groups, which is the least medical finding here and possibly the most useful. And frequent hot flashes were not a risk factor for recurrence, which quietly undercuts the idea that all of this is downstream of bad nights. If your nights are the loudest symptom, the fatigue that comes with them is worth separating from mood rather than merged into it.
What do women who have been through this actually report?
We read three discussion threads on the r/Menopause forum, dated between January and May 2026, carrying roughly 270 comments between them. These are accounts, not evidence: nobody in them has been examined and no outcome has been measured. What they show is where the guidance meets the appointment.
In a January 2026 thread with 359 upvotes and 146 comments, the woman who started it described asking her telehealth menopause provider about her hormone treatment, because her anxiety spiked in the second half of her cycle, and being offered two additional psychiatric medicines instead. The replies formed a queue of the same shape: mood raised, antidepressant offered, hormones never discussed. One commenter described being told by a gynaecologist that perimenopause was not real.
An April 2026 thread was built around sharing that Australian journal article before an appointment, which tells you how much of this reading women are now doing for themselves. The most upvoted replies were not against medication. They were about being offered only one of the two possible explanations.
The thread that cuts hardest against the pattern is a May 2026 one asking whether antidepressants alone had worked for anyone. The dominant answer, including from a moderator of the forum, was both, not either. Several described antidepressants that had worked for years seeming to lose their footing in their forties. Several said they could not take hormone therapy for medical reasons and that an antidepressant had helped. One said flatly that depression is often not hormonal, and was upvoted for it. That range matters, because the loud version of this conversation online is hormones good, antidepressants bad, and the women living it are far more careful than that.
So the accounts agree with NICE and the 2026 Australian review that hormonal treatment is often not raised at all, and with the 2018 guideline that where depression predates midlife, treating the depression is not optional. Both can be true, because they answer different questions.
What is worth raising with a doctor?
The 2018 guideline says diagnosis “involves identification of menopausal stage, assessment of co-occurring psychiatric and menopause symptoms, appreciation of the psychosocial factors common in midlife, differential diagnoses, and the use of validated screening instruments”. That is a list of five things, and an appointment that covers one of them has covered one of them. The Australian review names an instrument built for this, the Meno-D rating scale, which scores twelve symptoms. Neither replaces a clinician’s judgement.
Worth having written down before you go: when the low mood started relative to any change in your cycles, whether it moves in a pattern across the month or sits flat, whether you have been depressed before and what happened then, and whether anyone in your family has been. A symptom diary kept over a couple of cycles does that job better than memory does, and it makes it harder to be sent away with you are too young for this.
When does low mood need help today?
Some of this does not wait for a hormone conversation. If you are having thoughts of harming yourself, that needs help today, not at the next available appointment. In the United States, the 988 Suicide and Crisis Lifeline can be reached by call or text at any hour. In the United Kingdom and Ireland, Samaritans can be reached free on 116 123. Emergency services are the right call if you are not safe now.
This is not a rare corner of the subject. An observational report from a UK menopause clinic, presented as a conference abstract covering 1,212 patients, found that 16 per cent said they had experienced thoughts of self harm or suicidal ideation on at least some days in the previous fortnight. The caveats belong in the same breath: it is a conference abstract rather than a peer reviewed paper, and these patients had already sought out a private menopause clinic, so the percentage is not a general population rate. It is still a number worth knowing exists.
Depression in midlife is treatable whichever explanation turns out to fit, and it deserves the same urgency as depression at any other age. Being in perimenopause is not a reason to wait it out. It is a reason to be specific about what changed and when, and to keep asking until someone engages with the whole picture rather than the most convenient part of it.
Frequently asked questions
Is this depression, or is it perimenopause?
That question does not have a clean answer, and the guidance disagrees on whether it is even the right question. The 2018 NAMS and NNDC guideline treats depression in midlife as depression, presenting with classic symptoms alongside menopause symptoms that muddle the picture. The 2026 Australian review treats perimenopausal depression as a distinct pattern that fluctuates week to week. A clinician works it out from your history, your cycles and how the mood behaves over time, not from a single appointment or a single blood test.
Can perimenopause cause depression in someone who has never had it?
It happens, but it is not the usual story. The 2018 guideline states that most women who have a major depressive episode during perimenopause have had an episode before. SWAN found that first episodes in midlife tracked more with prior medical conditions, physical limitations and trait anxiety than with menopausal stage, while recurrences tracked with menopausal stage itself. A first ever episode in your forties is real and deserves attention, not a wait and see.
Does the low mood stop once periods stop?
Not reliably, on the numbers. In the SWAN analysis that followed 221 women for ten years, the odds of a major depressive episode were higher in early postmenopause than in perimenopause, though the confidence interval on that figure is very wide. The 2018 guideline defines the vulnerable window as including early postmenopause, not ending at the final period. Anyone told to hold on until it is over is being given a timeline nobody can promise.
Are hormone blood tests useful for working this out?
For most women over 45 they add little, because levels swing hour to hour and a single reading describes only that hour. NICE guideline NG23 identifies perimenopause without laboratory tests in otherwise healthy people aged 45 and over, and says to consider a serum FSH test in people aged 40 to 45. No test tells you whether low mood is hormonal. A normal result does not close the question.
Why do antidepressants that used to work seem to stop working?
Women report this often, and it is one of the most common themes in the forum threads read for this article. The 2026 Australian review states that women in this stage often respond poorly to antidepressants. That is a published claim rather than a settled finding, and the 2018 guideline reaches a different conclusion about first-line treatment. If a medicine that used to work no longer seems to, that is information for the person who prescribed it, not a reason to change anything alone.
Is anxiety part of the same problem?
It travels with it closely enough that separating them in a ten minute appointment is hard. The 2026 Australian review puts fluctuating anxiety and agitation at the beginning of the pattern it describes, before low mood becomes obvious. SWAN found a history of anxiety disorder predicted recurrence of major depression in midlife. Worth mentioning anxiety explicitly rather than waiting to be asked, because it is often the symptom that arrives first.
This article is general information, not medical advice, and is not a substitute for care from a qualified healthcare professional. Speak to your doctor about your own situation.
Leave a Reply